AGI-134

SKU: orb2567067

Description

AGI-134 is a synthetic alpha-Gal glycolipid that activates CD8+ T cell-mediated immunity, leading to targeted tumor cell lysis and phagocytosis. This mechanism supports its research application in studying immunotherapeutic strategies against cancer in both in vitro and in vivo experimental models.

Key Properties

• CAS Number: 1821461-84-0
• MW: 1456.73
• Formula: C₇₀H₁₂₆N₃O₂₆P
• SMILES: O([C@@H]1[C@@H](CO)O[C@@H](OCCCNC(CCCCC(NCCOP(OC[C@H](OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O)(=O)O)=O)=O)[C@H](NC(C)=O)[C@H]1O)[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@@H](CO)O2
• Target: Others

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

92131145